Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis.
about
pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic AgentsIron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.The Microbiome in Cystic Fibrosis.Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.The Dynamics of Disease Progression in Cystic Fibrosis.Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function DeclinePseudobacteremia outbreak of biofilm-forming Achromobacter xylosoxidans - environmental transmission.Mycobacterium abscessus-Induced Granuloma Formation Is Strictly Dependent on TNF Signaling and Neutrophil Trafficking.Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputaIdentification and analysis of genomic islands in Burkholderia cenocepacia AU 1054 with emphasis on pathogenicity islands.Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.One Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation.Deletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulentExposing the Three-Dimensional Biogeography and Metabolic States of Pathogens in Cystic Fibrosis Sputum via Hydrogel Embedding, Clearing, and rRNA Labeling.Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs.Genomics Reveals a Unique Clone of Burkholderia cenocepacia Harboring an Actively Excising Novel Genomic Island.In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection.Class III Histidine Kinases: a Recently Accessorized Kinase Domain in Putative Modulators of Type IV Pilus-Based Motility.Infection in cystic fibrosis: impact of the environment and climate.Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.Lipopolysaccharide modification in Gram-negative bacteria during chronic infection.Cystic Fibrosis: Microbiology and Host ResponseInhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.Role of AxyZ Transcriptional Regulator in Overproduction of AxyXY-OprZ Multidrug Efflux System in Achromobacter Species Mutants Selected by Tobramycin.Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.Intracellular survival of Burkholderia cepacia complex in phagocytic cells.Comparative Genomics of Burkholderia singularis sp. nov., a Low G+C Content, Free-Living Bacterium That Defies Taxonomic Dissection of the Genus Burkholderia.Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study.Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections.Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa.Antimicrobial activity of six essential oils against Burkholderia cepacia complex: insights into mechanism(s) of action.Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.Burkholderia cenocepacia Induces Macropinocytosis to Enter Macrophages.Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans.Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy
P2860
Q28070241-0DE215E0-BA12-4DC7-8C9F-3DA93BB0D812Q35862783-86E39B3C-6827-474A-92E3-5F9CCE676480Q35864774-2F2B7943-2599-4F0B-8219-D44E3AEABA42Q35917770-235E3680-9DA1-4B93-8F64-F7C0DEB64DBFQ35918209-1EF7E28F-1F63-4EFC-8F70-B17C989D0AF0Q36036190-1E374FF7-1A38-490A-BDE4-B10BFDE4858FQ36061478-F5B3DD92-6A28-40F3-BCCD-338EFDB5AA73Q36063996-1CF1D308-0E69-4230-84F4-428619FCD546Q36166643-B88A0D00-88F4-4D05-8EA7-679DD35D5729Q36180493-0D6FCDB0-00D4-4DE0-84ED-895306BB6CD6Q36304192-923B387B-444B-446D-81C1-515BEF22E8A4Q36324439-228BBE5F-57D7-4B13-9F0E-DEC37BF67D91Q36709312-32C98555-CF77-4ACC-8B19-DA54C4608E74Q37094805-11584436-CD8B-497E-BB59-2DC6F74A7FE6Q37126863-3A87A3BA-FDD6-47AD-9CA5-88AE5451E466Q37292246-EB2494C4-87C4-40CC-BE83-FF2C5B3BDFA4Q37735527-B1A7B9E2-16E4-4F02-A732-22FEEBC266C6Q37739134-27318A7D-00FD-4BEC-89FC-CA9E366F3B02Q38619135-37CB09AB-BCED-40CD-A57E-77A8D4527191Q38686249-86A2160A-6F71-42DE-B705-ECAB1E200A6CQ38763542-5CD9CE80-4DBC-492A-B616-B79350EABEFBQ38764394-9A84788E-987E-41E3-9150-BC75D9B5A971Q38807634-09853775-F5DB-4305-9B99-8D50021647A6Q38911644-2D91E0A2-B137-4B9B-93F9-91AD780E992CQ38991210-BD9F3422-A497-4BA1-A9F4-DBA838A0CABFQ40090307-023CB8A6-487E-4FC8-BA13-44679FB13563Q40184199-F21D732B-2918-47E3-AFBC-4E1A1AD54A2AQ40226374-2CCAD6A2-88D5-4C61-A4E1-5555099E92C1Q40252432-9F1F8C43-6848-4939-AE18-F3B942CE10B5Q41085038-BB401459-DA3A-4373-BD03-E1AE07A620F8Q41440455-1A0D7EF1-B9BA-4E5F-9073-E7319AB7EB94Q47097212-D7648FA6-4D58-40DD-AA0B-6E9E814DE205Q47155202-C2698B06-0F5C-4EC1-930C-B3EB11AADC15Q47200948-A6263292-129B-4190-ACFC-874E71E4492CQ47324867-850EF6E4-DFBA-4113-8F21-6ABCB3B6DCEBQ47803718-037C1304-BA21-4F94-B23C-D5963B70487CQ47814293-D9BAD1AD-A4B9-404C-9BB2-21C40C09D3C2Q55044583-6EE0F575-3068-4029-9020-1358B39A7FAAQ55387697-69549624-0607-4285-AC39-04EA93DA6A0CQ56523707-0B56492D-1636-47FB-A350-60577D6220A0
P2860
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging bacterial pathogens a ...... thogenesis in cystic fibrosis.
@ast
Emerging bacterial pathogens a ...... thogenesis in cystic fibrosis.
@en
type
label
Emerging bacterial pathogens a ...... thogenesis in cystic fibrosis.
@ast
Emerging bacterial pathogens a ...... thogenesis in cystic fibrosis.
@en
prefLabel
Emerging bacterial pathogens a ...... thogenesis in cystic fibrosis.
@ast
Emerging bacterial pathogens a ...... thogenesis in cystic fibrosis.
@en
P1476
Emerging bacterial pathogens a ...... thogenesis in cystic fibrosis.
@en
P2093
Michael D Parkins
R Andres Floto
P304
P356
10.1016/J.JCF.2015.03.012
P577
2015-04-14T00:00:00Z